RxDoctor Payments Data

Jennifer Cook, APRN

Family · Meridian, IDNPI 1073858049

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.2% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 45.6% of the total. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,568in general payments, 2019–2025

Across 220 payments — averaging $25.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Regeneron Healthcare Solutions, Inc.$943
  • Novartis$560
  • Sun Pharmaceutical Industries Inc.$291
  • Johnson & Johnson$238
  • Dermavant Sciences, Inc.$230
  • plus $770 from 9 others

What the payments were for

  • Food & beverage$5,24694%
  • Education$3216%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,568 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$97,498
Medicare patients
436
Services billed
2,601

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$7,348
Metronidazole33$3,626
Azelaic Acid24$2,941
Ketoconazole144$2,556
Clobetasol Propionate51$1,674
Fluorouracil12$1,371
Clindamycin Phosphate24$1,153
Betamethasone Dipropionate20$969
Betamethasone Valerate22$871
Desonide37$830
Triamcinolone Acetonide95$714
Ciclopirox32$683
Mometasone Furoate48$675
Doxycycline Monohydrate18$466
ValacyclovirValacyclovir Hcl29$444

Paid to pharmacies, not to this prescriber.

Other family in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →